Show simple item record

dc.contributor.authorGonzález-Touya, Marta
dc.contributor.authorCarmona-Alferez, Rocio 
dc.contributor.authorSarría-Santamera, Antonio 
dc.date.accessioned2022-04-19T11:54:48Z
dc.date.available2022-04-19T11:54:48Z
dc.date.issued2021-07-12
dc.identifier.citationHealthcare (Basel). 2021;9(7):873.es_ES
dc.identifier.issn2227-9032es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14111
dc.description.abstractBackground: Diabetes mellitus is a significant public health problem. Macrovascular complications (stroke, acute myocardial infarction (AMI) and lower limb amputations (LLAs) represent the leading cause of morbi-mortality in DM. This work aims to evaluate the impact of the approval of the Diabetes Mellitus Strategy of the National Health System (SDM-NHS) on hospitalizations for those macrovascular complications related to DM. Methods: Interrupted time series applying segmented regression models (Negative Binomial) adjusted for seasonality to data from hospital discharge records with a primary or secondary diagnosis of DM (code 250 ICD9MC). Results: Between 2001 and 2015, there have been 7,302,750 hospital discharges with a primary or secondary diagnosis of DM. After the approval of the SDM-NHS, all the indicators showed a downward trend, modifying the previous trend in the indicators of AMI and LLA. The indicators of stroke and AMI also showed an immediate reduction in their rates. Conclusions: After the approval of the SDM-NHS, an improvement has been observed in all the indicators of macrovascular complications of DM evaluated, although it is difficult to establish a causal relationship between the strategy and the effects observed. Interrupted time series is applicable for evaluating the impact of interventions in public health when experimental designs are not possible.es_ES
dc.description.sponsorshipThis research was partially funded by the Nazarbayev University #080420FD1916.es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI) es_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectComorbidityes_ES
dc.subjectDiabetes mellituses_ES
dc.subjectHealth plan implementationes_ES
dc.subjectInterrupted time serieses_ES
dc.subjectPredictive and preventive strategieses_ES
dc.subjectPublic policies evaluationes_ES
dc.titleEvaluating the Impact of the Diabetes Mellitus Strategy for the National Health System: An Interrupted Time Series Analysises_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID34356251es_ES
dc.format.volume9es_ES
dc.format.number7es_ES
dc.format.page873es_ES
dc.identifier.doi10.3390/healthcare9070873es_ES
dc.contributor.funderNazarbayev University (Kazajstán)es_ES
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.3390/healthcare9070873es_ES
dc.identifier.journalHealthcare (Basel, Switzerland)es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional